This special blog post is reprinted with permission from the Eye on IVD newsletter and features an interview with Kalorama Senior Editor Daniel Granderson, offering insights into the IVD market outlook for 2026. Before we shift attention to J.P. Morgan Healthcare this year, let’s get a sense of where we are in in vitro diagnostics […]
Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain Arlington, VA — June 2025 — A new survey of 195 diagnostic imaging and clinical lab professionals reveals that tariff policy uncertainty is already changing how providers plan staffing, purchasing, and vendor relationships. The latest Beyond the Bench […]
Kalorama Information is proud to introduce our recent report, The World Market for Cancer Diagnostics, 2024-2029. This comprehensive analysis provides an authoritative overview of the global cancer in vitro diagnostics (IVD) market, highlighting key trends, market sizing, and growth opportunities. In this report, you’ll find an in-depth review of the cancer IVD market, enriched with expert […]
The lab diagnostics industry is evolving at an unprecedented pace, driven by shifting regulations, decentralized testing growth, and rapid advancements in molecular and point-of-care technologies. Companies relying on outdated anecdotal insights or outdated data risk falling behind in a competitive landscape where market shifts and customer demands evolve in real time. “Custom Competitive Intelligence (CI) […]
In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success […]
Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It’s more than just bringing a product to market—it’s about aligning your offering with market needs, targeting the right audience, and positioning your brand for success. In this blog, we explore the essential steps and strategies necessary to […]
Cell and gene therapy is attracting much attention these days and for good reason. For one, there has been a notable increase in the number of cell and gene therapies in clinical development over the past decade. In the United States alone there are over 1,000 cell and gene therapies in clinical development, and more […]
The Home IVD testing market is not new, but it had primarily been limited to glucose and pregnancy testing. COVID-19 testing has opened the door for home infectious disease testing and more. The market is detailed in Kalorama’s latest report At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023 https://kaloramainformation.com/product/at-home-diagnostic-testing-markets-and-trends-covid-19-fob-glucose-hiv-and-other-tests-2023/ The global Home IVD testing market was […]
The global market for clinical laboratory services grew to an estimated $168.3 billion during 2022. This is according to Kalorama’s latest report on clinical lab services (https://kaloramainformation.com/product/clinical-laboratory-services-market-8th-edition/) The COVID-19 testing demand increased the market by more than $31 billion over the year. Besides the remarkable and continued growth in 2022 due to COVID-19 demand, there are a number of […]
When a market declines in momentum, it’s easy to forget that it still contributes to the overall market. This is the case with COVID-19. Testmakers are separating revenues to be sure investors know the parts of their business growing and declining and what part is related to the now-endemic disease. However, this belies the fact […]
